First-In-Class Bronchiectasis Treatment Among 14 Drugs Awaiting EMA Verdict

 
• By Vibha Sharma
  
Evaluating the pros and cons of a business contract. Debate and compromise about a business deal. Dispute about the positive and negative aspects.
Sponsors of 14 new drugs could learn if their products are on track for EU-wide approval (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from EU CHMP

More from Product Reviews